Structure via PubChem · Public domain (PubChem)
pilsicainide
Sign in to saveAlso known as N-(2,6-dimethylphenyl)-2-(1,2,3,5,6,7-hexahydropyrrolizin-8-yl)acetamide
Pilsicainide (INN) is an antiarrhythmic agent. It is marketed in Japan as サンリズム (Sunrythm). It was developed by Suntory Holdings Limited and first released in 1991. The JAN applies to the hydrochloride salt, pilsicainide hydrochloride.
Chemical data
- Formula
- C17H24N2O
- Molecular weight
- 272.4 g/mol
- IUPAC name
- N-(2,6-dimethylphenyl)-2-(1,2,3,5,6,7-hexahydropyrrolizin-8-yl)acetamide
- SMILES
- CC1=C(C(=CC=C1)C)NC(=O)CC23CCCN2CCC3
- InChIKey
- BCQTVJKBTWGHCX-UHFFFAOYSA-N
- XLogP
- 2.7
- Polar surface area
- 32.3 Ų
- H-bond donors
- 1
- H-bond acceptors
- 2
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Phase 2
- Molecule type
- Small molecule
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 272.189
Show 4 more facts
- canonical SMILES
- CC1=C(C(=CC=C1)C)NC(=O)CC23CCCN2CCC3
- chemical formula
- C₁₇H₂₄N₂O
- subject has role
- sodium channel blocker
- Commons category
- Pilsicainide
Sources (2)
via Wikidata · CC0
~4 min read
Encyclopedic overview
3 sectionsContents
- Medical uses
- Pharmacology
- References
Pilsicainide (INN) is an antiarrhythmic agent. It is marketed in Japan as サンリズム (Sunrythm). It was developed by Suntory Holdings Limited and first released in 1991. The JAN applies to the hydrochloride salt, pilsicainide hydrochloride.
== Medical uses ==
Excerpted from Wikipedia’s “pilsicainide” article, available under the CC BY-SA 4.0 licence.